Replies to post #355471 on Amarin Corp Plc (AMRN)

[dukesking]

Thanks Raf!

[rosemountbomber]

Thanks Raf.

[ralphey]

Total generic 2000 total vascepa 6000 ( increase ) meaning generics are now eating 30% of the pie - Id eliminate all reps until such time that the market is restored

[daviscupper]

Thank you for your hard work and due diligence. Looks pretty good to me. Moving in the right direction.

[Number sleven]

Raf, Thanks for the numbers.
Sleven,

[Jasbg]

raf, Thanks - Vasepa crossed the 100.000 line in USA. Now we only need Marjac to, ensure that patients are secured 'the real thing' - Brand Vascepa in the future.
-----------------------

Hikma now has 780+ products'.

https://www.hikma.com/products/

Dr. Reddy has more than 900 products:

https://www.drreddys.com/germany/our-products/
---------------

Vasepa' - for these big Generic Company's - is 'just another copy product'.

For Amarin and its Users 'Brand Vascepa' is about Life and Death.

[rafunrafun]

Scripts for week ending September 24, 2021

Overall drug TRx are -0.4% w/w

Vascepa
TRx 82,667; +0.7% (+568) w/w; -11.3% y/y
NRx 37,394; +0.7% (+274) w/w; -14.8% y/y
Ref 45,273; +0.7% (+294) w/w; -8.3% y/y

Lovaza (Generic & Brand)
TRx 64,191; -0.1% (-75) w/w; -0.8% y/y
NRx 31,167; -0.8% (-240) w/w; -4.9% y/y
Ref 33,024; +0.5% (+165) w/w; +3.4% y/y

Generic Vascepa
TRx 19,143; -0.6% (-120) w/w; As % of total V: 18.8%
NRx 10,757; -0.8% (-84) w/w; As % of total V: 22.3%
Ref 8,386; -0.4% (-36) w/w; As % of total V: 15.6%

Generic Vascepa by Manufacturer
Hikma - TRx 12,753 (-81); Generic share 66.6%; Total V share 12.5%
Reddy - TRx 6,391 (-39); Generic share 33.4%; Total V share 6.3%

TRx Vascepa + Generic Vascepa: 101,810 (+447)